130 related articles for article (PubMed ID: 22155101)
1. Fluticasone propionate and Salmeterol combination induces SOCS-3 expression in airway epithelial cells.
Nasreen N; Khodayari N; Sukka-Ganesh B; Peruvemba S; Mohammed KA
Int Immunopharmacol; 2012 Jan; 12(1):217-25. PubMed ID: 22155101
[TBL] [Abstract][Full Text] [Related]
2. Fluticasone furoate is more effective than mometasone furoate in restoring tobacco smoke inhibited SOCS-3 expression in airway epithelial cells.
Nasreen N; Gonzalves L; Peruvemba S; Mohammed KA
Int Immunopharmacol; 2014 Mar; 19(1):153-60. PubMed ID: 24434372
[TBL] [Abstract][Full Text] [Related]
3. Combined fluticasone propionate and salmeterol reduces RSV infection more effectively than either of them alone in allergen-sensitized mice.
Singam R; Jena PK; Behera S; Hellermann GR; Lockey RF; Ledford D; Mohapatra SS
Virol J; 2006 May; 3():32. PubMed ID: 16719922
[TBL] [Abstract][Full Text] [Related]
4. Fluticasone, but not salmeterol, reduces cigarette smoke-induced production of interleukin-8 in human airway smooth muscle.
Oltmanns U; Walters M; Sukkar M; Xie S; Issa R; Mitchell J; Johnson M; Chung KF
Pulm Pharmacol Ther; 2008; 21(2):292-7. PubMed ID: 17692547
[TBL] [Abstract][Full Text] [Related]
5. Salmeterol/fluticasone combination in the treatment of COPD.
Chung KF
Int J Chron Obstruct Pulmon Dis; 2006; 1(3):235-42. PubMed ID: 18046860
[TBL] [Abstract][Full Text] [Related]
6. Corticosteroids and beta2 agonists differentially regulate rhinovirus-induced interleukin-6 via distinct Cis-acting elements.
Edwards MR; Haas J; Panettieri RA; Johnson M; Johnston SL
J Biol Chem; 2007 May; 282(21):15366-75. PubMed ID: 17395587
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study.
Ferguson GT; Calverley PMA; Anderson JA; Jenkins CR; Jones PW; Willits LR; Yates JC; Vestbo J; Celli B
Chest; 2009 Dec; 136(6):1456-1465. PubMed ID: 19581353
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
9. Salmeterol with fluticasone enhances the suppression of IL-8 release and increases the translocation of glucocorticoid receptor by human neutrophils stimulated with cigarette smoke.
Mortaz E; Rad MV; Johnson M; Raats D; Nijkamp FP; Folkerts G
J Mol Med (Berl); 2008 Sep; 86(9):1045-56. PubMed ID: 18600309
[TBL] [Abstract][Full Text] [Related]
10. Adding salmeterol to fluticasone propionate or increasing the dose of fluticasone propionate in patients with asthma.
Delea TE; Hagiwara M; Stempel DA; Stanford RH
Allergy Asthma Proc; 2010; 31(3):211-8. PubMed ID: 20615321
[TBL] [Abstract][Full Text] [Related]
11. Long-term treatment with fluticasone propionate/salmeterol via Diskus improves asthma control versus fluticasone propionate alone.
Katial RK; Bernstein D; Prazma CM; Lincourt WR; Stempel DA
Allergy Asthma Proc; 2011; 32(2):127-36. PubMed ID: 21189151
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients.
Dransfield MT; Feldman G; Korenblat P; LaForce CF; Locantore N; Pistolesi M; Watkins ML; Crim C; Martinez FJ
Respir Med; 2014 Aug; 108(8):1171-9. PubMed ID: 24998880
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effects of fluticasone propionate and salmeterol on in vitro T-cell activation and apoptosis in asthma.
Pace E; Gagliardo R; Melis M; La Grutta S; Ferraro M; Siena L; Bonsignore G; Gjomarkaj M; Bousquet J; Vignola AM
J Allergy Clin Immunol; 2004 Nov; 114(5):1216-23. PubMed ID: 15536434
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effects of fluticasone propionate and salmeterol on inhibiting rhinovirus-induced epithelial production of remodelling-associated growth factors.
Volonaki E; Psarras S; Xepapadaki P; Psomali D; Gourgiotis D; Papadopoulos NG
Clin Exp Allergy; 2006 Oct; 36(10):1268-73. PubMed ID: 17014435
[TBL] [Abstract][Full Text] [Related]
15. Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma.
Pavord I; Woodcock A; Parker D; Rice L;
Respir Res; 2007 Sep; 8(1):67. PubMed ID: 17897478
[TBL] [Abstract][Full Text] [Related]
16. Effect of combining salmeterol and fluticasone on the progression of airway remodeling.
Vanacker NJ; Palmans E; Pauwels RA; Kips JC
Am J Respir Crit Care Med; 2002 Oct; 166(8):1128-34. PubMed ID: 12379559
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the efficacy and safety of once-daily fluticasone furoate/vilanterol with twice-daily fluticasone propionate/salmeterol in moderate to very severe COPD.
Agustí A; de Teresa L; De Backer W; Zvarich MT; Locantore N; Barnes N; Bourbeau J; Crim C
Eur Respir J; 2014 Mar; 43(3):763-72. PubMed ID: 24114969
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of salmeterol/fluticasone propionate versus fluticasone propionate in asthma patients: a randomized, double-blind study.
Lee YS; Lin HC; Huang CD; Lee KY; Liu CY; Yu CT; Wang CH; Kuo HP
Chang Gung Med J; 2011; 34(4):382-94. PubMed ID: 21880193
[TBL] [Abstract][Full Text] [Related]
19. Influence of salmeterol/fluticasone via single versus separate inhalers on exacerbations in severe/very severe COPD.
Hagedorn C; Kässner F; Banik N; Ntampakas P; Fielder K
Respir Med; 2013 Apr; 107(4):542-9. PubMed ID: 23337300
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
Daley-Yates PT; Mehta R; Chan RH; Despa SX; Louey MD
J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):279-89. PubMed ID: 24074143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
